يعرض 1 - 10 نتائج من 87 نتيجة بحث عن '"Carboxypeptidase A3"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المصدر: Tuberculosis and Lung Diseases; Том 102, № 1 (2024); 26-33 ; Туберкулез и болезни легких; Том 102, № 1 (2024); 26-33 ; 2542-1506 ; 2075-1230

    وصف الملف: application/pdf

    العلاقة: https://www.tibl-journal.com/jour/article/view/1790/1799Test; Будневский А.В., Авдеев С.Н., Овсянников Е.С., Шишкина В.В., Есауленко Д.И., Филин А.А., Савушкина И.А., Первеева И.М., Алексеева Н.Г. Роль тучных клеток и их протеаз в поражении легких у пациентов с COVID-19 // Пульмонология. – 2023. – Т. 33, №1. – С.17-26.; Овсянников Е.С., Авдеев С.Н., Будневский А.В., Дробышева Е.С., Кравченко А.Я. COVID-19 и хроническая обструктивная болезнь легких: известное о неизвестном // Туберкулез и болезни легких. – 2021. – Т. 99, №2. – С.6-15.; Ярошецкий А.И., Грицан А.И., Авдеев С.Н. и др. Диагностика и интенсивная терапия острого респираторного дистресс-синдрома (Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов») // Анестезиология и реаниматология. – 2020. – №2. – С.5–39.; Abonia J.P., Blanchard C., Butz B.B., et al. Involvement of mast cells in eosinophilic esophagitis // J Allergy Clin Immunol. – 2010. – Vol.126, №1. – Р.140-149.; Abramczyk U., Nowaczyński M., Słomczyński A., Wojnicz P., Zatyka P., Kuzan A. Consequences of COVID-19 for the Pancreas // Int J Mol Sci. – 2022. – Vol.23, №2. – Р.864.; Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in MCs activation syndrome// Int. J. Infect. Dis. – 2020. – №100. – Р.327–332.; Atiakshin D., Kostin A., Trotsenko I., Samoilova V., Buchwalow I., Tiemann M. Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells// Cells. – 2022. – Vol.11, № 3. – Р.570.; Atiakshin D.A., Shishkina V.V., Esaulenko D.I., Ovsyannikov E.S., Antakova L.N., Gerasimova O.A., Samoilenko T.V., Andreev P.Yu., Magerramova S.T., Budnevskaya S.A. Mast cells as the target of the biological effects of molecular hydrogen in the specific tissue microenvironment // International Journal of Biomedicine. – 2022. – Vol. 12, № 2. – Р.183-187.; Azkur A.K., Akdis M., Azkur D., Sokolowska M., et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19 //Allergy. –2020. – Vol.75, №7. – Р.1564-1581.; Buchwalow I. B., Böcker W. Immunohistochemistry: basics and methods. – Springer Science & Business Media, 2010.; Budnevsky A.V., Avdeev S.N., Kosanovic D., Shishkina V.V., Filin A.A., Esaulenko D.I., Ovsyannikov E.S., Samoylenko T.V., Redkin A.N., Suvorova O.A., Perveeva I.M. Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients // Respiratory Research. –2022. – Vol.23, №1. – Р.1-10.; Campillo-Navarro M., Chávez-Blanco A.D., Wong-Baeza I., Serafín-López J., Flores-Mejía R., Estrada-Parra S., Estrada-García I., Chacón-Salinas R. Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity // Curr Respir Med Rev. – 2014. – Vol.10, № 2. – Р.115-123.; Dougherty R.H., Sidhu S.S., Raman K., Solon M., Solberg O.D., Caughey G.H., Woodruff P.G., Fahy J.V. Accumulation of intraepi-thelial mast cells with a unique protease phenotype in T(H)2-high asthma // J. Allergy Clin. Immunol. – 2010. – № 125. –Р.1046–1053.; Dubey L., Dorosh O., Dubey N., et al. COVID-19-induced coagulopathy: Experience, achievements, prospects // Cardiol J. – 2023. – Vol. 30, № 3. – Р.453-461.; Gebremeskel S., Schanin J., Coyle K.M., Butuci M., Luu T., Brock E.C., Xu A., Wong A., Leung J., Korver W., Morin R.D., Schleimer R.P., Bochner B.S., Youngblood BA. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody // Front Immunol. – 2021. –№12. – Р.650331.; George P.M., Wells A.U., Jenkins R.G. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy // Lancet Respir Med. – 2020. – Vol. 8, № 8. – Р.807-815.; Jafarzadeh A., Chauhan P., Saha B., Jafarzadeh S., Nemati M. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions // Life Sci. – 2020. –№ 257. – Р.118102.; Kempuraj D., Selvakumar G.P., Ahmed M.E., et al. COVID-19, MastCells, Cytokine Storm, Psychological Stress, and Neuroinflammation // Neuroscientist. –2020. – Vol.26, № 5-6. – Р. 402-414.; Kritas S.K., Ronconi G., Caraffa A., Gallenga C.E., Ross R., Conti P. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy // J Biol Regul Homeost Agents. – 2020. – Vol.34, № 1. – Р.9-14.; Kudlay D., Kofiadi I., Khaitov M. Peculiarities of the T cell immune response in COVID-19. Vaccines. 2022; 10(2): 242.; Palladino M. Complete blood count alterations in COVID-19 patients: A narrative review // Biochem Med (Zagreb). – 2021. – Vol. 31, № 3. – Р.030501.; Siddhuraj P., Clausson C.M., Sanden C., Alyamani M., Kadivar M., Marsal J., Wallengren J., Bjermer L., Erjefält J.S. Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3 // Cells. –2021. – Vol. 10, №2. – Р.309.; Siddhuraj P., Jönsson J., Alyamani M., et al. Dynamically upregulated mast cell CPA3 patterns in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis // Front Immunol. –2022. – №13. – Р.924244.; Soria-Castro R., Meneses-Preza Y.G., Rodríguez-López G.M., Romero-Ramírez S., Sosa-Hernández V.A., Cervantes-Díaz R., et al. Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin // J Leukoc Biol. – 2021. – Vol.110, № 3. – Р.425-431.; Uhlén M., Fagerberg L., Lindskog C., et al. Proteomics. Tissue-based map of the human proteome // Science. – 2015. – Vol.347, № 6220. – Р.1260419.; https://www.tibl-journal.com/jour/article/view/1790Test

  3. 3
    دورية أكاديمية
  4. 4
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المصدر: International Journal of Molecular Sciences; Volume 24; Issue 7; Pages: 6498

    جغرافية الموضوع: agris

    وصف الملف: application/pdf

    العلاقة: Molecular Immunology; https://dx.doi.org/10.3390/ijms24076498Test

  8. 8
    دورية أكاديمية

    المساهمون: There was no sponsorship or financial support for the article, Спонсорская и финансовая поддержка работы отсутствовала

    المصدر: PULMONOLOGIYA; Том 33, № 1 (2023); 17-26 ; Пульмонология; Том 33, № 1 (2023); 17-26 ; 2541-9617 ; 0869-0189

    وصف الملف: application/pdf

    العلاقة: https://journal.pulmonology.ru/pulm/article/view/4123/3491Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1474Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1475Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1476Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1477Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1478Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1479Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1480Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1481Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1482Test; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4123/1483Test; Министерство здравоохранения Российской Федерации. Временные методические рекомендации: Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 15 (22.02.2022). Доступно на: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/%D0%92%D0%9C%D0%A0_COVID-19_V15.pdfTest [Дата обращения: 15.07.22].; Theoharides T.C. Potential association of mast cells with coronavirus disease 2019. Ann. Allergy Asthma Immunol. 2021; 126 (3): 217–218. DOI:10.1016/j.anai.2020.11.003.; Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in MCs activation syndrome. Int. J. Infect. Dis. 2020; 100: 327–332. DOI:10.1016/j.ijid.2020.09.016.; Krystel-Whittemore M., Dileepan K.N., Wood J.G. Mast cell: a multi-functional master cell. Front. Immunol. 2016; 6: 620. DOI:10.3389/fimmu.2015.00620.; Atiakshin D.A., Shishkina V.V., Esaulenko D.I. et al. Mast cells as the target of the biological effects of molecular hydrogen in the specific tissue microenvironment. Int. J. Biomed. 2022; 12 (2): 183–187. DOI:10.21103/Article12(2)_RA2.; Jing H., Liu L., Zhou J., Yao H. Inhibition of C-X-C motif chemokine 10 (CXCL10) protects mice from cigarette smoke-induced chronic obstructive pulmonary disease. Med. Sci. Monit. 2018; 24: 5748–5753. DOI:10.12659/MSM.909864.; Budnevsky A.V., Ovsyannikov E.S., Shishkina V.V. et al. Possible unexplored aspects of COVID-19 pathogenesis: the role of Carboxypeptidase A3. Int. J. Biomed. 2022; 12 (2): 179–182. DOI:10.21103/Article12(2)_RA1.; Nagashima S., Dutra A.A., Arantes M.P. et al. COVID-19 and lung mast cells: the kallikrein-kinin activation pathway. Int. J. Mol. Sci. 2022; 23 (3): 1714. DOI:10.3390/ijms23031714.; Lam H.Y., Tergaonkar V., Kumar A.P., Ahn K.S. Mast cells: Therapeutic targets for COVID-19 and beyond. IUBMB Life. 2021; 73 (11): 1278–1292. DOI:10.1002/iub.2552.; Elieh Ali Komi D., Wöhrl S., Bielory L. Mast cell biology at molecular level: a comprehensive review. Clin. Rev. Allergy Immunol. 2020; 58 (3): 342–365. DOI:10.1007/s12016-019-08769-2.; Kempuraj D., Selvakumar G.P., Ahmed M.E. et al. COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist. 2020; 26 (5-6): 402–414. DOI:10.1177/1073858420941476.; Theoharides T.C. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Biofactors. 2020; 46 (3): 306–308. DOI:10.1002/biof.1633.; Kosanovic D., Luitel H., Dahal B.K. et al. Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis. Eur. Respir. J. 2015; 46 (4): 1084–1094. DOI:10.1183/09031936.00018215.; Banin I.N., Budnevsky A.V., Grechkin V.I. et al. The experience of surfactant therapy in severe COVID-19 pneumonia: a case report. Int. J. Biomed. 2021; 11 (2): 177–180. DOI:10.21103/Article11(2)_CR1.; Ярошецкий А.И., Грицан А.И., Авдеев С.Н. и др. Диагностика и интенсивная терапия острого респираторного дистресс-синдрома (Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов»). Анестезиология и реаниматология. 2020; (2): 5–39. DOI:10.17116/anaesthesiology20200215.; ARDS Definition Task Force, Ranieri V.M., Rubenfeld G.D. et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012; 307 (23): 2526–2533. DOI:10.1001/jama.2012.5669.; Buchwalow I.B., Boecker W. Immunohistochemistry: basics and methods. Berlin: Springer; 2010.; Atiakshin D., Buchwalow I., Samoilova V., Tiemann M. Tryptase as a polyfunctional component of mast cells. Histochem. Cell Biol. 2018; 149 (5): 461–477. DOI:10.1007/s00418-018-1659-8.; Atiakshin D., Buchwalow I., Tiemann M. Mast cell chymase: morphofunctional characteristics. Histochem. Cell Biol. 2019; 152 (4): 253–269. DOI:10.1007/s00418-019-01803-6.; Шишкина В.В., Клочкова С.В., Алексеева Н.Т. и др. Триптазный профиль популяции тучных клеток кожи крыс при раневом процессе. Журнал анатомии и гистопатологии. 2020; 9 (4): 84–89. DOI:10.18499/2225-7357-2020-9-4-84-89.; Motta Junior J.D.S., Miggiolaro A.F.R.D.S., Nagashima S. et al. Mast cells in alveolar septa of COVID-19 patients: a pathogenic pathway that may link interstitial edema to immunothrombosis. Front. Immunol. 2020; 11: 574862. DOI:10.3389/fimmu.2020.574862.; Zhou Z., Ren L., Zhang L. et al. Heightened Innate Immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020; 27 (6): 883–890.e2. DOI:10.1016/j.chom.2020.04.017.; Gebremeskel S., Schanin J., Coyle K.M. et al. Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: Implications for an Anti-Siglec-8 antibody. Front. Immunol. 2021; 12: 650331. DOI:10.3389/fimmu.2021.650331.; Tan J., Anderson D.E., Rathore A.P.S. et al. Signatures of mast cell activation are associated with severe COVID-19. MedRxiv. 2021; 2021.05.31.21255594. DOI:10.1101/2021.05.31.21255594.; Soria-Castro R., Meneses-Preza Y.G., Rodríguez-Lopez G.M. et al. Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin. J. Leukoc. Biol. 2021; 110 (3): 425–431. DOI:10.1002/JLB.4HI0221-087R.; Afrin L.B. Presentation, diagnosis, and management of mast cell activation syndrome. In: Murray D.B., ed. Mast cells: Phenotypic features, biological functions and role in immunity. Hauppoge: Nova Science Publishers; 2013: 155–232. Available at: https://www.jillcarnahan.com/downloads/MCAS-Afrin.pdfTest [Accessed: July 10, 2022].; Vliagoftis H., Lacy P., Luy B. et al. Mast cell tryptase activates peripheral blood eosinophils to release granule-associated enzymes. Int. Arch. Allergy Immunol. 2004; 135 (3): 196–204. DOI:10.1159/000081304.; Lippi G., Plebani M., Henry B.M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin. Chim. Acta. 2020; 506: 145–148. DOI:10.1016/j.cca.2020.03.022.; Zhao X., Wang K., Zuo P. et al. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictive, preventive, and personalized medical approach. EPMA J. 2020; 11 (2): 139–145. DOI:10.1007/s13167-020-00208-z.; https://journal.pulmonology.ru/pulm/article/view/4123Test

  9. 9
  10. 10